Hitchwood Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-250,000
Closed -$15.8M 59
2021
Q3
$15.8M Hold
250,000
0.46% 47
2021
Q2
$22.9M Hold
250,000
0.42% 47
2021
Q1
$17M Hold
250,000
0.39% 47
2020
Q4
$18.1M Buy
+250,000
New +$14.5M 0.31% 51

Other funds holding CDNA

Hitchwood Capital Management's CDNA Position: Q4 2021 in Review

Hitchwood Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 250,000 shares — an estimated $15.8M sold.

Hitchwood Capital Management first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $22.9M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Hitchwood Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Hitchwood Capital Management sold 250,000 CareDx shares in Q4 2021, an estimated $15.8M.
  • Hitchwood Capital Management first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
  • Hitchwood Capital Management's CareDx position peaked at $22.9M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Hitchwood Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.